PFE lags the market as COVID sales drop and patent losses loom, but new drugs and cost cuts may fuel a comeback.

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no ...

Chart Industries has pivoted toward expanding its specialty portfolio of products into high-growth areas such as hydrogen and liquefied natural gas. It made several attractive investments and joint ...